Perbedaan UBC Medical Indonesia Tbk. dan Teladan Prima Agro Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb), sedangkan Teladan Prima Agro Tbk. diperdagangkan di Rp545 (kapitalisasi pasar 7,31 T, volume 24 jam 1,25 jt). Perbedaan utamanya: Teladan Prima Agro Tbk. jauh lebih besar — sekitar 11,5× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Teladan Prima Agro Tbk. lebih aktif diperdagangkan (1,25 jt vs 843 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | TLDN | |
|---|---|---|
Kapitalisasi Pasar | 635,95 M | 7,31 T |
Volume | 843 rb | 1,25 jt |
Lot | 8,43 rb | 12,48 rb |
Perputaran | 137,6 jt | 687,74 jt |
Harga Rata-rata | 163,22 | 551,16 |
Nilai Transaksi | 137,6 jt | 687,74 jt |
Harga Ekuilibrium Indikatif | 165 | 545 |
Volume Ekuilibrium Indikatif | 246 | 917 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Teladan Prima Agro Tbk ( formerly PT Sandaran Prima Sawit ) was established in the Republic of Indonesia on May 10, 2004 based on the Notarial Deed No. 22 of Imas Fatimah, S.H. On May 25, 2012, the Company's shareholders approved the proposed merger with PT Teladan Agro Resources (“TAR”) where the Company is the recipient of the merger (“Penggabungan 2012”).
Selengkapnya di halaman TLDN →